Neuroscience Futures: Cellas Hayes, Ph.D.
| When |
April 23, 2024
4 p.m. to 5 p.m.
|
|---|---|
| Where |
Campus:
Building:
3232 SW Research Drive
Portland,
Oregon
97239
Room: M1441
We hope you will join us in-person to network with our speaker and your colleagues. If you are unable to be on campus we will provide an online option. Register to receive the live-stream link. |
| Contact Information |
Exploring the Interplay of Vascular Pathologies, Alzheimer’s Disease, and Lewy Body Disease on Harmonized Cognitive Measures
Dr. Cellas Hayes completed his undergraduate degrees in Biology/Classics/Latin at the University of Mississippi in 2019. He continued his doctoral studies at his undergraduate alma mater and received his Ph.D. in Pharmaceutical Sciences with an emphasis in Pharmacology in the laboratory of Dr. Nicole Ashpole. Dr. Hayes was the first black trainee and the first trainee in 37 years to receive a NIH F31 at the University of Mississippi to study the cellular mechanisms of post-stroke neuroprotection of insulin-like growth factor-1 using in vitro and in vivo preclinical models.
While pursuing his Ph.D., he was admitted into the prestigious Smith Scholars program at the University of Mississippi Medical Center Graduate Educational Training Center. The Smith Scholars program afforded Dr. Hayes the opportunity to study systemic inflammation as a biomarker for non-fatal stroke incidence in the Jackson Heart Study using traditional epidemiology approaches and statistical analyses. Dr. Hayes became the first Black individual to receive a Ph.D. in Pharmaceutical Sciences from UM.
Dr. Hayes is currently a postdoctoral fellow in Dr. Michelle Odden laboratory at Stanford University. His research interest vascular contributions to cognition and biomarkers related to other neurodegenerative diseases such as Alzheimer’s Disease and Lewy Body Disease. Dr. Hayes’ research pursuits include understanding the comorbid associations of Alzheimer’s Disease and cerebrovascular disease in diverse populations with the hopes of identifying fluid biomarkers using multidimensional biological data and advanced biostatistics. Lastly, Dr. Hayes is also extremely passionate about increasing and maintaining diversity and inclusion in STEM fields through mentorship, service, and teaching.
Dr. Hayes’ presentation for the Neuroscience Futures Seminar Series will focus on his work quantifying the heterogenous contributions of cerebrovascular neuropathologies with Alzheimer’s disease and Lewy Body Disease in the National Alzheimer’s Coordination Center.